Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Patient Related Outcome Measures|October 17, 2018
Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to dateLindsey Hathaway, Jeremy Michael Sen, Michael KengCurrent Hematologic Malignancy Reports|March 30, 2017
New Therapeutic Strategies in Acute Lymphocytic LeukemiaLouise M Man, Amy L Morris, Michael KengCurrent Hematologic Malignancy Reports|May 1, 2020
MLL-Rearranged Acute Lymphoblastic LeukemiaFiras El Chaer, Michael Keng, Karen K BallenPsychiatry (Edgmont (Pa. : Township))|September 30, 2010
Phenobarbital-induced bullous lesions in a non-comatose patientMichael Keng, Maritza Lagos, Michael R Liepman, et al.Current Hematologic Malignancy Reports|February 23, 2026
Inotuzumab Ozogamicin in Clinical Practice: an Overview of Efficacy, Safety, and Real-World ApplicationsValerie Tran, Nandan Srinivasa, Caroline Tatum, et al.Current Hematologic Malignancy Reports|July 12, 2026
Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic LeukemiaLiesl S Eibschutz, Samuel Crow, Caroline Tatum, et al.Oncotargets and Therapy|January 23, 2023
Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future DirectionsIndumathy Varadarajan, Eric Pierce, Lisa Scheuing, et al.Current Hematologic Malignancy Reports|December 7, 2023
Blinatumomab in PracticeJeffrey Lantz, Natalie Pham, Caroline Jones, et al.JCO Oncology Practice|February 13, 2020
Prospective Initiative to Reduce Mucosal Barrier Injuries and Bloodstream Infections in Patients With Hematologic Malignancy Receiving Inpatient ChemotherapyDaniel Reed, Jeremy Sen, Katie Lassiter, et al.Current Hematologic Malignancy Reports|June 18, 2024
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical ImplicationsValerie Tran, Kiarash Salafian, Kenan Michaels, et al.Pageof 3